Relay Therapeutics (RLAY) News
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
16.12+0.21 (+1.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RLAY news summary
We found 2 recent headlines mentioning Relay Therapeutics (RLAY): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, RLAY is up 1.32% at $16.12. The most recent story, "Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November", was published by GlobeNewswire on Nov 2, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Relay Therapeutics headlines
- Relay Therapeutics to Participate in Three Upcoming Investor Conferences in NovemberCAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies…GlobeNewswire
- Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026CAMBRIDGE, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies…GlobeNewswire